A new study by researchers from the Brown University School of Public Health found that pregnant women are regularly excluded from clinical drug trials that test for safety, raising… read more.
GSK plc announced the European Commission has approved Jemperli (dostarlimab) in combination with chemotherapy (carboplatin and paclitaxel) for first-line treatment of adult patients with primary advanced or recurrent… read more.
Women diagnosed with multiple sclerosis (MS) have a significantly higher risk of developing mental illness during pregnancy and soon after birth compared to women who become pregnant while… read more.
Senior midwives and researchers with experience in criminal and social justice are among those calling for improved maternity provision for pregnant women in UK prisons. In an article… read more.
During IVF treatment, doctors use ultrasound scans to monitor the size of follicles – small sacs in the ovaries containing eggs – to decide when to give a… read more.
Theramex, a global pharmaceutical company dedicated to women’s health, is pleased to announce that the European Commission (EC) has approved an extended indication for Yselty (linzagolix), an oral… read more.
A new set of guidelines has been developed to assist with the diagnosis and expert management of serious blood cancers in pregnancy. About 12.5 pregnancies per 100,000 are… read more.
Women who experience infertility but do not use fertility treatments have a higher risk of developing a group of conditions called systemic autoimmune rheumatic diseases (SARD) in the… read more.
Researchers report that most treatments for pregnant women with MS (multiple sclerosis) do not lead to increased risks of major adverse outcomes. “We found that most therapies were… read more.
Many infants in Sweden are given milk cereal drinks, ready-to-mix liquid drink complements to breast milk, after six months of age. New research in Acta Paediatrica found evidence that these… read more.
AbbVie announced the European Commission (EC) granted marketing authorization for Elahere (mirvetuximab soravtansine) for the treatment of adult patients with folate receptor-alpha (FRα) positive, platinum-resistant high grade serous… read more.
The use of antidepressants is associated with sexual side effects including reduced genital sensitivity that persists after stopping the medication, a new Simon Fraser University study finds. The… read more.
Advertisment
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
